ObvioHealth Is Ready For Decentralized Trials To Continue Growth Post-Pandemic
ObvioHealth is redefining clinical trials with its remote approach to address poor-quality patient-reported data and high costs while simultaneously discovering new trial outcomes.
You may also be interested in...
Using artificial intelligence and strict data collection protocol, ObvioHealth hopes to digitize clinical trials with the assistance of medical devices and consumer technology.
Liquid biopsy represents potential advantages over traditional approaches to cancer surveillance, treatment selection and recurrence monitoring. But one size does not fit all, requiring tailored solutions for less developed markets.
The company has enrolled the first patient in the second human trial of its implantable metabolite monitoring system, which it expects could change the game for blood glucose measurement.